2025.02.02

One of our clients published preclinical data on NASH-fibrosis on Frontiers in Genetics

One of our clients FDA-National Center for Toxicological Research (NCTR) has published the results of a study using STAMTM model on Frontiers in Genetics.

Title: “Gene Expression and DNA Methylation Alterations During Non-alcoholic Steatohepatitis-Associated Liver Carcinogenesis”

 

By using STAMTM model (NASH-HCC model), they demonstrated that NASH-related HCC is characterized by progressive accumulation of gene expression and gene-specific DNA methylation changes, with the greatest magnitude being found in full-fledged HCC.

 

Please let me know if you would like further information on our NASH-HCC model (STAMTM model) and our services.